XML 138 R14.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Restructuring and other impairment charges
 12 Months Ended
Dec. 31, 2019
Restructuring and Related Activities [Abstract]  
Restructuring and impairment charges Restructuring and impairment charges
We have ongoing restructuring programs related to the relocation of manufacturing operations to existing lower-cost locations and related workforce reductions (referred to as our 2019, 2018 and 2014 Footprint realignment plans). The following tables provide a summary of our cost estimates and other information associated with these ongoing plans:
2019 Footprint realignment plan2018 Footprint realignment plan2014 Footprint realignment plan
Program expense estimates:(Dollars in millions)
Termination benefits
$19 to $23
$60 to $70
$12 to $13
Other costs (1)
1 to 2
2 to 4
1 to 2
Restructuring charges
20 to 25
62 to 74
13 to 15
Restructuring related charges (2)
36 to 45
40 to 59
34 to 37
Total restructuring and restructuring related charges
$56 to $70
$102 to $133
$47 to $52
Other program estimates:
Expected cash outlays
$53 to $66
$99 to $127
$38 to $43
Expected capital expenditures
$29 to $35
$19 to $23
$25 to $30
Other program information:
Period initiatedFebruary 2019May 2018 April 2014
Estimated period of substantial completion202220242021
Aggregate restructuring charges
$13.8
$54.1
$13.0
Restructuring related charges incurred:
For year ended December 31, 2019
$6.1
$3.0
$3.2
Aggregate restructuring related charges
$6.6
$7.2
$32.2

(1)Includes facility closure, employee relocation, equipment relocation and outplacement costs.
(2)Restructuring related charges represent costs that are directly related to the programs and principally constitute costs to transfer manufacturing operations to the existing lower-cost locations, project management costs and accelerated depreciation. The 2018 Footprint realignment plan also includes a charge associated with our exit from the facilities that is expected to be imposed by the taxing authority in the affected jurisdiction. Excluding this tax charge, substantially all of these charges are expected to be recognized within cost of goods sold.
The following table summarizes the restructuring reserve activity related to our 2019, 2018 and 2014 Footprint realignment plans:
2019 Footprint realignment plan2018 Footprint realignment plan2014 Footprint realignment plan
(Dollars in thousands)
Balance at December 31, 2017$—  $—  $3,926  
Subsequent accruals—  54,993  830  
Cash payments—  (4,503) (820) 
Foreign currency translation—  (2,016) —  
Balance at December 31, 2018—  48,474  3,936  
Subsequent accruals13,753  (939) 313  
Cash payments(1,602) (3,628) (580) 
Foreign currency translation and other(281) 367  —  
Balance at December 31, 2019 (1)
$11,870  $44,274  $3,669  
(1)The restructuring reserves as of December 31, 2019 , 2018 and 2017 consisted mainly of accruals related to termination benefits. Most of the Other costs (facility closure, employee relocation, equipment relocation and outplacement costs) were expensed and paid in the same period.
The restructuring and impairment charges recognized for the years ended December 31, 2019, 2018, and 2017 consisted of the following:
2019
Termination benefits
Other Costs (1)
Total
(Dollars in thousands) 
2019 Footprint realignment plan$13,683  $70  $13,753  
2018 Footprint realignment plan(1,787) 848  (939) 
Other restructuring programs (2)
787  1,638  2,425  
Total restructuring charges12,683  2,556  15,239  
Asset impairment charges—  6,966  6,966  
Total restructuring and impairment charges$12,683  $9,522  $22,205  

2018
Termination benefits
Other Costs (1)
Total
(Dollars in thousands) 
2018 Footprint realignment plan$53,992  $1,001  $54,993  
Other restructuring programs (3)
3,820  1,307  5,127  
Total restructuring charges57,812  2,308  60,120  
Asset impairment charges—  19,110  19,110  
Total restructuring and impairment charges$57,812  $21,418  $79,230  

2017
Termination benefits
Other Costs (1)
Total
(Dollars in thousands) 
2017 Vascular Solutions integration program (4)
$5,377  $118  $5,495  
2017 EMEA restructuring program (5)
4,921  280  5,201  
Other restructuring programs (6)
3,018  1,076  4,094  
Total restructuring charges$13,316  $1,474  $14,790  
(1) Includes facility closure, contract termination and other exit costs.
(2) Includes activity primarily related to a restructuring program initiated in the third quarter of 2019 that is designed to reduce costs and improve efficiencies through reorganizations within several businesses and certain corporate functions and the 2014 Footprint realignment plan.
(3) Includes activity primarily related to the 2016 Footprint realignment plan, which is substantially complete, and the 2014 Footprint realignment plan, as well as the 2017 Vascular Solutions integration program and the 2017 EMEA restructuring program, both of which are described below.
(4) The program was initiated in 2017 and was related to the integration of Vascular Solutions into Teleflex and has been substantially completed.
(5) The program was initiated in 2017 to centralize certain administrative functions in Europe and has been substantially completed.
(6) Includes activity primarily related to the 2016 Footprint realignment plan, the 2014 Footprint realignment plan and the other 2016 restructuring programs.
Impairment Charges
For the year ended December 31, 2019 and 2018, we recorded impairment charges of $7.0 million and $19.1 million, respectively, related to our decision to abandon certain intellectual property and other assets associated with our interventional product portfolio. There were no impairment charges recorded for the year ended December 31, 2017.